CXCL10 and diffuse large B-cell lymphoma: CXCL10 expression levels detected from the blood of patients with DLBCL were reported in three prospective studies, each including 185 (Ansell et al., 2012), 276 (Witzig et al., 2014) and 313 (Hong et al., 2017) patients, to correlate with higher IPI scores and significant inferior prognoses.